Tag: U.S

U.S. Department of Health and Human Services and The Rockefeller Foundation Partner to Accelerate the Adoption of Food is Medicine in Health Systems

WASHINGTON | January 31, 2024 ― The U.S. Department of Health and Human Services (HHS) and The Rockefeller Foundation announced a new partnership to accelerate the adoption of Food is Medicine in health systems. Through this partnership, HHS and The Rockefeller Foundation aim to improve health outcomes and health equity by engaging a broader public audience in understanding nutrition, accelerating collective understanding of Food is Medicine interventions and their impacts, and exploring strategies to scale successful Food Is Medicine programs to more eligible Americans.

“We know good food is the foundation of good health, and study after study has found Food is Medicine interventions can make people healthier while reducing health care costs,” said Dr. Rajiv J. Shah, President of The Rockefeller Foundation. “I am proud The Rockefeller Foundation will be collaborating with HHS to help improve health outcomes and advance health equity by ensuring Food is Medicine interventions reach those who stand to benefit from them most.”

While Food is Medicine programs are widely recognized as powerful interventions, they only reach a fraction of those who could benefit. Through a public-private partnership, HHS and The Rockefeller Foundation will exchange information and ideas to:

  • Advance and leverage research design and findings through knowledge to produce definitive evidence on clinical health outcomes, cost effectiveness, and optimal program design.
  • Engage a broader public audience in the meaning and value of FIM interventions and resources.
  • Support Food is Medicine adoption by identifying opportunities and barriers to support greater uptake and scaling.
  • Ensure Food is Medicine supports diverse individuals and communities with a focus on health equity.

“HHS and The Rockefeller Foundation are working together to accelerate food as medicine adoption in various health systems and communities. We are eager to build on this dynamic opportunity and we anticipate powerful outcomes through collaborative

Mulvihill U.S. Health Care Enhanced Yield ETF Announces Semi-Annual Results

Article content

TORONTO, Aug. 29, 2023 (GLOBE NEWSWIRE) — (TSX: XLVE) Mulvihill U.S. Health Care Enhanced Yield ETF (the “Fund”) announces results of operations for the six months ended June 30, 2023. Decrease in net assets attributable to holders of Units amounted to $0.08 million or $0.13 per Unit. Net assets attributable to holders of Units as at June 30, 2023 were $7.10 million or $9.46 per Unit. Cash distributions of $0.29 per Unit were paid to unitholders during the period.

The Fund seeks to provide unitholders with long-term capital appreciation through exposure to a portfolio consisting principally of the U.S. health care issuers selected from the S&P 500 Index that are classified as “health care” by Standard and Poor’s Global Industry Classification Standard and monthly cash distributions.

Article content

To accomplish its objectives, the Fund invests in an actively managed portfolio comprised principally of securities from the S&P 500 Health Care Index. Modest leverage of 25 percent enhances the dividend yields of the underlying stocks and provides additional return potential. The Fund will also utilize option strategies to enhance the income generated by the portfolio and to reduce volatility. The Fund is also permitted to hedge all or a portion of the foreign currency exposure of the Fund’s portfolio back to the Canadian dollar.

The Fund’s investment portfolio is managed by its investment manager, Mulvihill Capital Management Inc.   The Fund’s Units are listed on Toronto Stock Exchange under the symbols XLVE.

Selected Financial Information: ($ Millions)
Statement of Comprehensive Income        
For the six months ended June 30, 2023        
Income (including Net Gain on Investments)   $ 0.09    
Expenses     (0.17 )  
Decrease in Net Assets Attributable to Holders of Units   $ (0.08 )  

For further information, please contact Investor Relations at 416.681.3966, toll free at 1.800.725.7172 or visit www.mulvihill.com

Cyberattack disrupts hospitals and health care in the U.S.


Hospitals and clinics in several states on Friday began the time-consuming process of recovering from a cyberattack that disrupted their computer systems, forcing some emergency rooms to shut down and ambulances to be diverted.

Many primary care services at facilities run by Prospect Medical Holdings remained closed on Friday as security experts worked to determine the extent of the problem and resolve it.

John Riggi, the American Hospital Association’s national advisory for cybersecurity and risk, said the recovery process can often take weeks, with hospitals in the meantime reverting to paper systems and humans to do things such as monitor equipment and run records between departments.

“These are threat-to-life crimes, which risk not only the safety of the patients within the hospital, but also risk the safety of the entire community that depends on the availability of that emergency department to be there,” Riggi said.

The latest “data security incident” began Thursday at facilities operated by Prospect, which is based in California and has hospitals and clinics there and in Texas, Connecticut, Rhode Island and Pennsylvania.

“Upon learning of this, we took our systems offline to protect them and launched an investigation with the help of third-party cybersecurity specialists,” the company said in a statement Friday. “While our investigation continues, we are focused on addressing the pressing needs of our patients as we work diligently to return to normal operations as quickly as possible.”

The White House has been monitoring the cyberattack, said Adrienne Watson, a spokesperson for the National Security Council.

Watson also said in a statement that “the Department of Health and Human Services has been in contact with the company to offer federal assistance, and we are ready to provide support as needed to prevent any

CFPB, U.S. Department of Health and Human Services, and U.S. Department of Treasury Launch Inquiry into Costly Credit Cards and Loans Pushed on Patients for Health Care Costs

WASHINGTON, D.C. – Today, the Consumer Financial Protection Bureau (CFPB), U.S. Department of Health and Human Services (HHS), and U.S. Department of Treasury (Treasury) launched an inquiry into high-cost specialty financial products, such as medical credit cards and installment loans, that are pushed on patients as a way to pay for routine medical care and which drive up health care costs and medical debt. Today’s request for information builds on CFPB research on medical payment products and medical billing and collections, in addition to other actions by the CFPB and Federal agencies to relieve the burden of medical debt and collections practices. The three agencies seek information about the prevalence of these products, patients’ experiences with them, and health care providers’ incentives to offer these high-cost products to patients, which may include avoiding the insurance claims process and financial assistance programs. The CFPB will use the public input as it considers ways to address the patient harms caused by these specialty financial products.

“Financial firms are partnering with health care players to push products that can drive patients deep into debt,” said CFPB Director Rohit Chopra. “We are opening a public inquiry to better understand how these practices are affecting patients in our country.”

“This inquiry builds on the Department’s work to protect patients from unfair billing practices, lower costs, and increase transparency in our health care system,” said HHS Secretary Xavier Becerra. “Hearing directly from patients about their experiences will help shape policies that can prevent families from incurring medical debt.”

“Treasury is proud to partner with agencies across the Biden Administration to crack down on these often abusive practices that take advantage of patients during vulnerable times. We look forward to receiving stakeholder input so that we can better protect patients and consumers,” said Deputy Secretary of the

11 U.S. stocks to seize the underperformance of the Health Care sector

What are we looking for?

For Canadian investors who predominantly focus on the domestic market, the health care sector may pose challenges because of its limited presence on the TSX. However, with the U.S. sector underperforming this year, with only a 2.2-per-cent increase compared with the S&P 500′s 15.1-per-cent gain, now might be an opportune moment to explore investment opportunities south of the border.

The screen

We screened U.S. stocks in the health-care sector focusing on the following criteria:

  • Market capitalization greater than US$5-billion;
  • StockPointer (SP) score higher than 60 – the score mainly considers risk-adjusted return on capital, earnings-per-share growth and free-cash-flow per share. The score varies between zero and 100. A score of 60 implies a better-than-average company;
  • Relative Economic Performance Index greater than 0.6 – Relative EPI is a calculation that compares the profitability of a company with its valuation and cost of capital. Higher profitability, a lower valuation and a lower cost of capital increase the ratio;
  • For informational purposes, we have also included three-month and 12-month NOPAT (net operating profit after tax) growth, five-year free-cash-flow to capital, one-year price performance and dividend yield. Please note that some ratios may be shown as of the end of the previous quarter.

More about Inovestor

Inovestor, a prominent Canadian fintech company with more than 20 years of experience, has partnered with Morningstar in an alliance, solidifying Inovestor’s unrivaled position as the industry’s leading alternative tool. To learn more visit our website.

What we found

U.S. Health Care stocks 

MCKESSON CORPORATION MCK-N 420.88 57240 82 1.0 12.5 11.7 52.0 16.7 28.3 0.5

B.C. sends patients to U.S. plus other letters, May 22: ‘Code for private health care’

Open this photo in gallery:

The B.C. government has announced that beginning May 29, it would send about 50 breast and prostate cancer patients per week to the U.S. for care.Amy Romer/The Globe and Mail

Field trip

Re “Sending B.C. cancer patients to U.S. for care will triple the cost” (May 18): British Columbia spent millions of taxpayer dollars fending off a challenge to the Medicare Protection Act. Throughout the years-long legal battle, the government’s position was that even a modicum of private health care would be the first step down the “slippery slope” to the dreaded U.S. system.

Now we learn the government will use the U.S. system, at great public expense, to provide treatment to cancer patients within recommended timelines. On one hand, the government should be congratulated for recognizing that timely care must be a priority. Under the current circumstances, the best, perhaps only, option lies south of the border.

But why? The government created barriers that effectively prevented building the very facilities now being used in Bellingham, Wash. Had that not been the case, treatments could have been provided by the private sector in B.C., keeping health care dollars in the province and providing care closer to home.

Geoff Holter Vancouver

British Columbia, like most provinces, is facing increasing demand for health care, made worse by an aging population.

The solution for increased demand should be to increase supply, something that seems to have been missed by the B.C. government. Instead, it found an “outlet valve” in Bellingham, Wash. It should be noted that “outlet valve” reads as code for private health care.

This same government was so critical of the Cambie Surgery Centre, all because doctor Brian Day had the audacity to suggest there might be a place for private health care when governments

13 U.S. health care stocks starting to shine again

What are we looking for?

U.S. health care stocks that are benefiting from a sector rotation.

Upside momentum seems to be entering the U.S. health care sector as it takes top spot over the past five trading days, followed by the energy and utilities sectors. The S&P 500 Healthcare Sector SPDR (XLV-A) fund ETF has gained approximately 4 per cent over the past week. Health care providers and pharmaceutical stocks are pushing the sector higher. Trading Central’s analyst desk in Ottawa dug deeper into the sector and built a strategy that outperforms the broad market if the health care sector continues to outperform.

The screen

We used Trading Central Strategy Builder to search for U.S. health care stocks with good valuations from a Quantamental perspective, which uses artificial intelligence and machine learning to rate stocks in the sector, price performance and a history of positive earnings growth.

We began by setting a minimum market capitalization threshold of US$10-billion to focus on larger, more established companies in the market.

Next, we screened for companies that are indicating an operating margin that is 10 per cent or higher in order to find profitable companies earning the most per dollar of revenue.

We like companies with a proven track record of earnings growth. Five-year EPS growth must be at least 10 per cent or higher.

Finally, we filtered for the top-rated stocks using Trading Central’s Quantamental rating method, which rates stocks on a scale of one to 10, with 10 being the most bullish and one being the most bearish. TC Quantamental rating uses a combination of valuation, growth, quality, price momentum and income as key metrics when rating a company. In our screen, we set a minimum rating of five out of 10 in order to screen for the top-rated companies.


Anti-trans U.S. expenditures now targeting adult well being care

Within just the past couple decades, hundreds of bills have been introduced in the U.S. with the aim of stripping away, limiting, or even criminalizing gender-affirming treatment for transgender youth underneath 18 many years of age, with proponents arguing that minors are too youthful to make these healthcare selections.

But in 2023, legislative tries to strip trans individuals of wellness-treatment selections have expanded their arrive at to a new age team: grownups.

In the earlier 3 months, at the very least 5 U.S. states have proposed costs that would limit gender-affirming care for older people either as a result of direct bans or by barring professional medical services and Medicaid from covering this care.

Two states — South Carolina and Texas — are looking at charges that would ban all gender-affirming treatment for individuals under the age of 26, modelled soon after an Oklahoma monthly bill introduced in January, nevertheless the age in that bill has given that been reduced to 18 soon after backlash. Kansas is considering banning gender-affirming treatment for individuals up to age 21.

“This is heading from just about every plan of liberty and opportunity in this nation,” Vivian Topping, director of advocacy and civic engagement at the Equality Federation, told CTVNews.ca in a mobile phone interview.

Gender-affirming treatment is medically necessary, evidence-centered care that allows trans and gender various men and women to transition to the gender that matches their lived expertise, in accordance to the top health care corporations in the U.S., which includes the American Health care Association and the American Academy of Pediatrics, which have condemned legislative attacks on this care.

Arguments in favour of banning treatment for trans people are mainly made by conservative lawmakers, who feel they are shielding kids and that minors

Back To Top